SCHEMBL755153

SCHEMBL755153

Cc1ccc(S(=O)(=O)CI)c([N+](=O)[O-])c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.53
CYP3A4 P08684 2/20 0.53
MCOLN3 Q8TDD5 1/20 0.50
ALDH1A1 P00352 3/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
MAPK1 P28482 1/20 0.44
CYP2C19 P33261 1/20 0.44
HIF1A Q16665 1/20 0.44
GAA P10253 1/20 0.44
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
NFKBIA P25963 1/20 0.43
AGTR1 P30556 1/20 0.43
OPRK1 P41145 1/20 0.43
RELA Q04206 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
RAB9A P51151 1/20 0.43
KAT2B Q92831 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1368484 0.83 TSHR (0.51) TSHRCYP3A4MCOLN3ALDH1A1CYP1A2
SCHEMBL14397142 0.82 ALDH1A1 (0.64) TSHRCYP3A4ALDH1A1CYP1A2CYP2D6
SCHEMBL754883 0.81 KIF18A (0.57) TSHRCYP3A4ALDH1A1CYP1A2CYP2D6
SCHEMBL4067424 0.80 TSHR (0.60) TSHRCYP3A4MCOLN3MEN1KMT2A
SCHEMBL10619019 0.80 TSHR (0.60) TSHRCYP3A4MCOLN3MEN1KMT2A
SCHEMBL17263332 0.79 ALDH1A1 (0.72) TSHRCYP3A4MCOLN3ALDH1A1CYP1A2
SCHEMBL137704 0.78 TSHR (0.58) TSHRCYP3A4MCOLN3MEN1KMT2A
SCHEMBL11119285 0.78 TSHR (0.58) TSHRCYP3A4MCOLN3MEN1KMT2A
SCHEMBL10515856 0.78 TSHR (0.58) TSHRCYP3A4MCOLN3ALDH1A1MEN1
SCHEMBL4807396 0.78 TSHR (0.58) TSHRCYP3A4MCOLN3ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2213166-B1 Biocidal compounds containing 2-methylisothiazolin-3-one and a haloalkylsulfone THOR GMBH (DE) 2012-03-21 EP claimed
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone THOR GMBH (DE) 2010-07-29 US claimed
US-8287631-B2 Compounds for preventing ghost odour THOR GMBH (DE) 2012-10-16 US disclosed
US-20100186631-A1 Compounds for preventing ghost odour THOR GMBH (DE) 2010-07-29 US disclosed
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone THOR GMBH (DE) 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone MBTD1, MPST, B2M TSHR 4791/4885CYP3A4 1279/4885MCOLN3 447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.